Analgesics - Ecuador

The systematic analgesic segment has experienced a slowdown in sales from August to December, 2009 due to a government ban on sales. The ban is a measure to prevent AH1N1 flu cases in Ecuador. Government hopes to prevent Ecuadorians from using self-medication when experiencing flu symptoms, so they will go to a doctor and if they have AH1N1 be properly diagnosed. The prohibition was extended to advertising and the promotion of systematic analgesics.

Euromonitor International's Analgesics Products in Ecuador report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health industry;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.